ID | 117805 |
著者 |
Bosman, Ariadne
University Medical Center Rotterdam
Palermo, Andrea
Universitario Campus Bio-Medico
Vanderhulst, Julien
Université Libre de Bruxelles
Jan De Beur, Suzanne M.
Johns Hopkins University
Minisola, Salvatore
“Sapienza” Rome University
Xia, Weibo
Peking Union Medical College
Body, Jean‑Jacques
Université Libre de Bruxelles
Zillikens, M. Carola
University Medical Center Rotterdam
|
キーワード | Tumor-induced osteomalacia
FGF23
Osteomalacia
Rickets
Hypophosphatemia
Fracture
|
資料タイプ |
学術雑誌論文
|
抄録 | Tumor-induced osteomalacia (TIO) is a rare and largely underdiagnosed paraneoplastic condition. Previous reviews often reported incomplete data on clinical aspects, diagnosis or prognosis. The aim of this study was to present a systematic clinical review of all published cases of TIO. A search was conducted in Pubmed, Embase, Web of Science from inception until April 23rd, 2020. We selected case reports and case series of patients diagnosed with TIO, with information on tumor localization and serum phosphate concentration. Two reviewers independently extracted data on biochemical and clinical characteristics including bone involvement, tumor localization and treatment. 468 articles with 895 unique TIO cases were included. Median age was 46 years (range 9 months–90 years) and 58.3% were males. Hypophosphatemia and inappropriately low or normal 1,25-dihydroxyvitamin D levels, characteristic for TIO, were present in 98% of cases. Median tumor size was 2.7 cm (range 0.5 to 25.0 cm). Serum fibroblast growth factor 23 was related to tumor size (r = 0.344, P < 0.001). In 32% of the cases the tumor was detected by physical examination. Data on bone phenotype confirmed skeletal involvement: 62% of cases with BMD data had a T-score of the lumbar spine ≤ − 2.5 (n = 61/99) and a fracture was reported in at least 39% of all cases (n = 346/895). Diagnostic delay was longer than 2 years in more than 80% of cases. 10% were reported to be malignant at histology. In conclusion, TIO is a debilitating disease characterized by a long diagnostic delay leading to metabolic disturbances and skeletal impairment. Increasing awareness of TIO should decrease its diagnostic delay and the clinical consequences.
|
掲載誌名 |
Calcified Tissue International
|
ISSN | 14320827
|
cat書誌ID | AA00141085
|
出版者 | Springer Nature
|
巻 | 111
|
号 | 4
|
開始ページ | 367
|
終了ページ | 379
|
発行日 | 2022-07-20
|
権利情報 | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
先端酵素学研究所
|